GSTM1 and benign neoplasm: The median tumor size, WBC count, Hb count, serum CRP level, and serum LDH level were 4.2 cm (0–27.3 cm), 5500/μL (2000–11,600/μL), 14.1 g/dL (7.7–18.1 g/dL), 0.05 mg/dL (0.01–8.03 mg/dL), and 180 IU/L (65–441 IU/L) in the benign tumor group; 11.5 cm (2.6–33.0 cm), 5800/μL (3900–12,200/μL), 14.2 g/dL (10.7–17.2 g/dL), 0.07 mg/dL (0.01–0.64 mg/dL), and 176 IU/L (129–294 IU/L) in the intermediate tumor group; and 8.8 cm (1.0–31.6 cm), 6500/μL (2500–18,100/μL), 13.2 g/dL (6.3–17.4 g/dL), 0.19 mg/dL (0.01–21.2 mg/dL), and 182 IU/L (117–2555 IU/L) in the malignant tumor group, respectively.